LAS VEGAS, Dec. 9, 2009 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI) and Alto Pharmaceuticals (www.altopharma.com), a dermatology-focused company based in Toronto, announced today they have entered into a license agreement for DermSafe(R), Skinvisible’s antimicrobial hand sanitizer lotion that recently completed clinical studies proving it kills the H1N1 virus. Under the terms of the agreement, Alto will pay Skinvisible an upfront license fee for the exclusive manufacturing and the commercial / professional use marketing rights for DermSafe in Canada. Skinvisible will also receive a royalty from product sales.
